Aurora ramps up medical cannabis production in Germany

Aurora ramps up medical cannabis production in Germany
Image by freepik

Aurora Cannabis was granted two licenses by the Federal Institute for Drugs and Medical Devices (BfArM). With the German cannabis market projected to reach €1.7 billion by 2025, the stage is set for companies like Aurora to gain big market share.

Canadian medical cannabis company Aurora Cannabis Inc.  has been granted two licenses by the Federal Institute for Drugs and Medical Devices (BfArM) under Germany’s new Medical Cannabis Act (MedCanG).

Continue reading.

Source:

Share